Free Trial

TC Biopharm (TCBPW) Competitors

TC Biopharm logo
$0.01 0.00 (-16.86%)
As of 02/21/2025 02:43 PM Eastern

TCBPW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying TC Biopharm stock or one of its competitors? The main competitors of TC Biopharm include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

TC Biopharm vs.

180 Life Sciences (NASDAQ:ATNFW) and TC Biopharm (NASDAQ:TCBPW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
TC Biopharm$2.86MN/AN/AN/AN/A

180 Life Sciences and TC Biopharm both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
TC BiopharmN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
TC Biopharm N/A N/A N/A

In the previous week, 180 Life Sciences had 1 more articles in the media than TC Biopharm. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for TC Biopharm. 180 Life Sciences' average media sentiment score of 1.38 beat TC Biopharm's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Positive
TC Biopharm Neutral

Summary

180 Life Sciences beats TC Biopharm on 2 of the 3 factors compared between the two stocks.

Get TC Biopharm News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCBPW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TCBPW vs. The Competition

MetricTC BiopharmBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$117.96M$5.84B$9.14B
Dividend YieldN/A3.69%4.76%3.85%
P/E RatioN/A3.2018.2614.95
Price / SalesN/A4,826.69434.4770.76
Price / CashN/A13.0138.4235.17
Price / BookN/A47.077.644.65
Net IncomeN/A-$87.82M$3.18B$245.69M
7 Day PerformanceN/A0.35%-1.95%-2.68%
1 Month PerformanceN/A3.62%-0.23%-2.16%
1 Year PerformanceN/A99.12%16.69%12.90%

TC Biopharm Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TCBPW
TC Biopharm
N/A$0.01
-16.9%
N/A-24.3%$0.00$2.86M0.0080Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-9.8%
N/A+51.5%$0.00N/A0.007News Coverage
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
+7.6%
N/A-13.4%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.10
-35.3%
N/A+138.5%$0.00$40,633.000.0040
ALVOW
Alvotech
N/A$2.36
+7.3%
N/A-46.2%$0.00$391.87M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
-7.2%
N/A-54.4%$0.00N/A0.004
BFRIW
Biofrontera
N/A$0.06
-6.3%
N/A+254.1%$0.00$35.36M0.0070High Trading Volume
BTMDW
biote
N/A$0.50
flat
N/A-46.2%$0.00$193.06M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.12
+22.4%
N/A-92.9%$0.00N/A0.008Gap Down
CELUW
Celularity
N/A$0.07
+14.3%
N/A+120.8%$0.00$48.20M0.00220Gap Up

Related Companies and Tools


This page (NASDAQ:TCBPW) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners